INVEST Pitch Perfect Spotlight: How DUOS Is Leveraging Tech To Support Older Adults
DUOS recently won the health tech consumer/employer track of MedCity News’ INVEST Pitch Perfect contest. The company supports older adults and their caregivers by addressing health-related social needs and connecting patients to care. The post INVEST Pitch Perfect Spotlight: How DUOS Is Leveraging Tech To Support Older Adults appeared first on MedCity News.
What a US Exit From the WHO Means for Global Health
For decades, the United States has held considerable power in determining the direction of global health policies and programs. President Donald Trump issued three executive orders on his first day in office that may signal the end of that era, health policy experts said. Trump’s order to withdraw from the World Health Organization means the…
Exercise Benefit in a Pill: BioAge Labs Goes Public, Raising More Than $200M for Clinical Trials
BioAge Labs’ lead drug candidate, azelaprag, is in Phase 2 testing in combination with Eli Lilly’s weight management medication Zepbound. The biotech’s oral drug activates a receptor it says can mimic certain biological effects of exercise. The post Exercise Benefit in a Pill: BioAge Labs Goes Public, Raising More Than $200M for Clinical Trials appeared…
How Routine Medical Care Fuels America’s Opioid Crisis
By MATT McCORD When most Americans undergo surgery, they expect to recover quickly and return to their normal lives. Few realize that something as routine as a shoulder surgery, a hernia repair, or a mastectomy can mark the beginning of a life-altering opioid addiction. This often-overlooked connection between routine medical care and opioid dependence demands…
AHIP to simplify prior authorization process
AHIP (formerly America’s Health Insurance Plans) released a statement yesterday saying that their health plan members “announced a series of commitments to streamline, simplify and reduce prior authorization.” 48 US health plans signed off on the statement. What were AHIP’s 6 commitments? Standardizing Electronic Prior Authorization. Participating health plans will work toward implementing common, transparent submissions…
Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare Disease With No Approved Drugs
Glycomine’s lead program is an experimental treatment for PMM2-CDG, an ultra-rare enzyme deficiency often misdiagnosed as cerebral palsy. With encouraging results from an open-label Phase 2 study, the biotech startup is now preparing for a placebo-controlled test that could potentially support a regulatory submission. The post Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare…
Strict Abortion Laws Is Likely Already Having An Economic Impact
A panel of experts said the HLTH conference agrred that states with strict abortion measures are likely to see negative economic impact as medical residents decline to go to them for training and physicians move out. The post Strict Abortion Laws Is Likely Already Having An Economic Impact appeared first on MedCity News.
How a New PE-Backed RCM Company Plans to Fix the ‘Transactional Bowels of US Healthcare’
Providers need a revenue cycle management platform that is more affordable and accurate, said Jeremy Dekinsky, CEO of Smarter Technologies, during MedCity News’ INVEST conference. New Mountain Capital formed Smarter Technologies this week by combining three separate platforms it had already acquired. The post How a New PE-Backed RCM Company Plans to Fix the ‘Transactional…
Seriously, Aon, you think weight loss drugs save money?
By AL LEWIS Last month Aon, the major benefits consulting firm, released a “study” claiming: A significant opportunity to reduce healthcare costs for employers and enhance overall workforce health through a comprehensive obesity management program that includes GLP-1 medications. This, of course, is the opposite of what most researchers have shown. And in the immortal…